Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. The company is headquartered in Bethesda, Maryland and currently employs 25 full-time employees. The company went IPO on 2001-12-14. The firm is focused on developing personalized immune therapies for cancer. The company has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The firm's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. The company has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, Northwest Biotherapeutics Capital Limited, Northwest Biotherapeutics B.V., Advent BioServices Ltd., and others.
NWBO stock price ended at $0.3 on Friday, after rising 3.45%
On the latest trading day Jan 23, 2026, the stock price of NWBO rose by 3.45%, climbing from $0.30 to $0.30. During the session, the stock saw a volatility of 6.90%, with prices oscillating between a daily low of $0.29 and a high of $0.31. Notably, trading volume dropped by 324.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 2.7M shares were traded, equating to a market value of approximately $458.6M.
NWBO Technical Signals
Technical Signals Summary
Buy Signals 5
Neutral Signals 2
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
NWBO currently exhibits 5 buy signals and 0 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of 3.45% during this period. Overall, the technical indicators point to a Strong Buy outlook for the mid-term.
Bullish/Bearish Signals for NWBO
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for NWBO. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to NWBO?
What are the Fibonacci retracement levels for NWBO?
What is the RSI for Northwest Biotherapeutics Inc?
What is Northwest Biotherapeutics Inc price for the next 12 months?
How high is Northwest Biotherapeutics Inc expected to go?